Good job from the directors, the start of the honey product expansion is under way.
This is what I've been saying all along, the base honey products is where the mainstream market revenue will come from. I think the cannabis side is just the hype, if they can get a range of organic products released that will lead them towards increasing revenue then the share price will reflect the value.
Still think it is slightly oversold at this point and would prefer to see 1.4-1.6c in the short term just to bring it more in-line with the 50% acquisition and the current news. This month they have still a number of announcements to go with the Omni Chinese deal and possibly an update on the base honey distribution to the US. Would not be surprised to see a run followed by a heavy sell-off from insiders acquiring at 1.8c and perhaps dumping at 2.4-2.8, will have to see how the day plays out though.
- Forums
- ASX - By Stock
- Ann: Meluka Health to Develop Honey Water for Chinese Market
Good job from the directors, the start of the honey product...
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.274M |
Open | High | Low | Value | Volume |
0.1¢ | 0.1¢ | 0.1¢ | $38 | 38.29K |
Featured News
EVE (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online